# AMETEK share price today (AMETEK, Inc., AME)

> AMETEK, Inc.'s results are improving, and its P/E is near the top of its own history, higher than 91% of past readings. AME · Industrials · Specialty Industrial Machinery · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ame

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from the last 12 quarters
- Price: $248.58 (+23.0% in a year)
- P/E: 35.1× (higher than 91% of the last 4.6 years)
- Revenue (Jun 2026): $2.0 B (+15.0% on a year ago)
- Profit (Jun 2026): $407 M (+13.5% on a year ago)
- Operating margin: 26.2% (+0.7 points on a year ago)
- ROE: 14%, FY25
- ROIC: 11.6%, against a 8.7% cost of capital: +2.9 points

The main question: results are strong, and the P/E is higher than 91% of its own history. ## What is the AMETEK share price today? AMETEK, Inc.'s share price was $248.58 at the close on 3 November 2026. It has been rising for 56 weeks. That is 6.0% above its average price over the last 200 trading days. In the last 52 weeks it traded between $193 and $255, and at that close it sat 90% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. Over the last 10 years the share price moved +442% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does AMETEK pay? AMETEK, Inc. paid $1.30 per share over the last four reported quarters. The most recent declaration was $0.34 for Jun 2026. At today's price of $248.58 that is a yield of 0.52%, based on dividends already paid, not a forecast. ## Which stock lists is AMETEK on? AMETEK is on one of our US lists: S&P 500 companies. [S&P 500 companies](https://www.sectoralpha.in/sp-500-stocks)

## Is AMETEK profitable? AMETEK, Inc. earned $407 M of net profit in the Jun 2026 quarter, +13.5% on the same quarter a year earlier. That is the 7th quarter in a row of profit growth. Full-year FY25 profit was $1.5 B. Over 4 years profit has grown 10.6% a year on average. That is 19.9% of the quarter's revenue. The same quarter a year earlier earned $358 M. For the full year, FY25 profit was $1.5 B (+7.6% on the year before). Why profit moved: revenue changed +15.0% on a year earlier and the margin moved +0.7 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +9.8% and revenue +12.6%. Profit and revenue are moving at about the same pace. ## How much revenue does AMETEK make, and is it growing? AMETEK, Inc. reported $2.0 B of revenue in the Jun 2026 quarter, +15.0% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 4 years it has grown 7.5% a year on average. The last full year, FY25, came in at $7.4 B. The last four reported quarters add to $7.9 B. FY25 revenue was $7.4 B, +6.6% on the year before. Recent pace: the last four quarters grew +12.6% on average, against 7.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +12.7%, against +7.3% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +9.6%, against +8.8% a year (stabilising). ## How much of every $100 of sales does AMETEK keep? AMETEK, Inc.'s operating margin was 26.2% in the Jun 2026 quarter, 0.7 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 23.6% and 26.2%. The latest quarter is within that range. Across 5 years it has been between 23.6% and 26.2%, and FY25's 26.2% is the highest of them. Why the margin moved: operating margin changed +0.7 percentage points on the year while gross margin changed +0.9 points. So the gain came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is AMETEK's profit turning into cash? Over the last 3 years, 129% of AMETEK, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $1.8 B of operating cash against $1.5 B of profit. After $130 M of spending on assets, $1.7 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does AMETEK's cash go? AMETEK, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $394 M on assets over the last 3 years. Averaged over those years that is 1.8% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $394 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is AMETEK's P/E ratio, and how does it compare with its own history? AMETEK, Inc.'s P/E is 35.1×, near the high end of its own history: higher than 91% of past readings. Its usual P/E (the middle reading) is 29.5×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +7.9% while the price moved +23.0%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved +20.0% a year; about +7.4% a year came from earnings growth and about +12.6 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the AMETEK business getting better or worse? AMETEK, Inc.'s business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 15.2%. This is based on 12 quarters of 4 measures. Why it matters: steady growth with healthy returns is how a business compounds over time. ## How much does AMETEK earn on its capital? AMETEK, Inc. earned a ROE of 14% in FY25. Its return on capital used (ROIC) is 2.9 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 20.0% net margin and 0.46× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 20.0% net margin × 0.46× asset turnover × 1.51× leverage (assets divided by equity) ≈ 13.9% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 11.6% − 8.7% = +2.9 percentage points. The 8.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 11.6% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 13.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does AMETEK have too much debt? AMETEK, Inc. has total debt of $2.3 B against shareholder equity of $11.3 B as of Jun 2026, so its debt is 0.21× its equity, which is very little. Year by year, that ratio went from 0.40 in FY21 to 0.24 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the AMETEK shareholding pattern? 1.6% of AMETEK, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so very few traders are betting against this stock. At normal trading volumes, closing those positions would take about 2.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is AMETEK from balance-sheet trouble? For AMETEK, Inc., the Z-score is 7.38. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 7.38 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does AMETEK rank in its industry? 55.9 out of 100, rank 10 of 30 in Specialty Industrial Machinery, with 81% of the evidence available. AMETEK, Inc. scores 55.9 out of 100 against the 30 companies it is compared with in Specialty Industrial Machinery, ranking 10. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.4 + 15.4 + 5.4 + 14.7 = 55.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is AMETEK compared with? AMETEK ranks 10 of 30 Specialty Industrial Machinery companies on the 4-Factor Sector Score, with 55.9 out of 100. 1. [Rockwell Automation, Inc.](https://www.sectoralpha.in/us/stocks/rok) ROK · turning · Most evidence points up · 81% evidence 70.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Revenue 11.3% · Profit 24.1% · Operating margin change 3.4 points · 83% evidence Capital efficiency 19.8/25 · ROCE 23.9% · Operating margin 21% · 76% evidence Valuation 8.7/20 · P/E 45.9× · PEG 1.82 · 65% evidence Relative strength 15.0/20 · Lead over its industry 4% · Lead over S&P 500 0.9% · 1 year 19.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.2 + 19.8 + 8.7 + 15 = 70.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Nordson Corporation](https://www.sectoralpha.in/us/stocks/ndsn) NDSN · leader · Most evidence points up · 85% evidence 68.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.9/35 · Revenue 7% · Profit 22% · Operating margin change 0.3 points · 95% evidence Capital efficiency 15.9/25 · ROCE 15% · Operating margin 27.4% · 76% evidence Valuation 12.9/20 · P/E 29.9× · PEG 1.23 · 65% evidence Relative strength 19.2/20 · Lead over its industry 14% · Lead over S&P 500 10.7% · 1 year 42.3% · 100% evidence · 9 of 12 weeks ahead Exact sum: 20.9 + 15.9 + 12.9 + 19.2 = 68.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Watts Water Technologies, Inc.](https://www.sectoralpha.in/us/stocks/wts) WTS · quiet · Most evidence points up · 81% evidence 67.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 17.1% · Profit 23.1% · Operating margin change -0.6 points · 83% evidence Capital efficiency 19.0/25 · ROCE 21.4% · Operating margin 20.9% · 76% evidence Valuation 12.0/20 · P/E 31.3× · PEG 1.35 · 65% evidence Relative strength 13.7/20 · Lead over its industry 10.1% · Lead over S&P 500 6.9% · 1 year 31.9% · 100% evidence · 3 of 12 weeks ahead Exact sum: 22.3 + 19 + 12 + 13.7 = 67 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Emerson Electric Co.](https://www.sectoralpha.in/us/stocks/emr) EMR · breaking out · Evidence leans up · 81% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 4.8% · Profit 0.1% · Operating margin change 2.1 points · 83% evidence Capital efficiency 17.3/25 · ROCE 16.8% · Operating margin 26.9% · 76% evidence Valuation 10.3/20 · P/E 31.1× · PEG 1.78 · 65% evidence Relative strength 19.3/20 · Lead over its industry 12.7% · Lead over S&P 500 9.3% · 1 year 28.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 17.3 + 17.3 + 10.3 + 19.3 = 64.2 · What this means: Relative strength against the index is 9.3%, and revenue and profit growth are weak. 5. [Illinois Tool Works Inc.](https://www.sectoralpha.in/us/stocks/itw) ITW · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 4.3% · Profit -5.1% · Operating margin change 0.3 points · 83% evidence Capital efficiency 20.9/25 · ROCE 41.8% · Operating margin 26.9% · 76% evidence Valuation 10.4/20 · P/E 24.4× · PEG 1.82 · 65% evidence Relative strength 15.4/20 · Lead over its industry 5.5% · Lead over S&P 500 2.1% · 1 year 16.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.3 + 20.9 + 10.4 + 15.4 = 64 · What this means: Relative strength against the index is 2.1%, and revenue and profit growth are weak. 6. [Crane Company](https://www.sectoralpha.in/us/stocks/cr) CR · quiet · Evidence leans up · 81% evidence 61.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Revenue 16.3% · Profit -4.3% · Operating margin change 17.8 points · 83% evidence Capital efficiency 17.1/25 · ROCE 18.3% · Operating margin 35.5% · 76% evidence Valuation 11.8/20 · P/E 38.3× · PEG 1.24 · 65% evidence Relative strength 12.6/20 · Lead over its industry 3.8% · Lead over S&P 500 0.6% · 1 year 9.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 19.5 + 17.1 + 11.8 + 12.6 = 61 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Dover Corporation](https://www.sectoralpha.in/us/stocks/dov) DOV · turning · Evidence leans up · 85% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue 8.2% · Profit -48.2% · Operating margin change 1 points · 95% evidence Capital efficiency 14.3/25 · ROCE 14.1% · Operating margin 19.7% · 76% evidence Valuation 16.0/20 · P/E 21.6× · PEG 0.22 · 65% evidence Relative strength 12.8/20 · Lead over its industry 1.8% · Lead over S&P 500 -1.7% · 1 year 18.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 17.1 + 14.3 + 16 + 12.8 = 60.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [GE Vernova Inc.](https://www.sectoralpha.in/us/stocks/gev) GEV · quiet · Evidence leans up · 85% evidence 58.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.6/35 · Revenue 16.9% · Profit 100% · Operating margin change 7.1 points · 95% evidence Capital efficiency 11.8/25 · ROCE 15.8% · Operating margin 12.8% · 76% evidence Valuation 7.5/20 · P/E 24.4× · PEG 2.79 · 65% evidence Relative strength 9.2/20 · Lead over its industry 2.5% · Lead over S&P 500 -0.7% · 1 year 59.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 29.6 + 11.8 + 7.5 + 9.2 = 58.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Flowserve Corporation](https://www.sectoralpha.in/us/stocks/fls) FLS · turning · Evidence leans up · 81% evidence 57.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.9/35 · Revenue -0.3% · Profit 27.4% · Operating margin change 0.6 points · 83% evidence Capital efficiency 10.6/25 · ROCE 13.2% · Operating margin 13.9% · 76% evidence Valuation 14.7/20 · P/E 25.5× · PEG 0.88 · 65% evidence Relative strength 15.2/20 · Lead over its industry 5.7% · Lead over S&P 500 2.1% · 1 year 17% · 100% evidence · 1 of 12 weeks ahead Exact sum: 16.9 + 10.6 + 14.7 + 15.2 = 57.4 · What this means: Relative strength against the index is 2.1%, and revenue and profit growth are weak. 10. AMETEK, Inc. this page AME · turning · Evidence leans up · 81% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Revenue 12.6% · Profit 9.7% · Operating margin change 0.7 points · 83% evidence Capital efficiency 15.4/25 · ROCE 14.9% · Operating margin 26.2% · 76% evidence Valuation 5.4/20 · P/E 35.2× · PEG 3.47 · 65% evidence Relative strength 14.7/20 · Lead over its industry 7.1% · Lead over S&P 500 3.8% · 1 year 26.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.4 + 15.4 + 5.4 + 14.7 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [IDEX Corporation](https://www.sectoralpha.in/us/stocks/iex) IEX · turning · Evidence leans up · 81% evidence 54.7 out of 100 Growth Capital Valuation Relative
12. [Otis Worldwide Corporation](https://www.sectoralpha.in/us/stocks/otis) OTIS · turning · Evidence leans up · 81% evidence 52.0 out of 100 Growth Capital Valuation Relative
13. [Donaldson Company, Inc.](https://www.sectoralpha.in/us/stocks/dci) DCI · quiet · Evidence leans up · 85% evidence 51.9 out of 100 Growth Capital Valuation Relative
14. [The Middleby Corporation](https://www.sectoralpha.in/us/stocks/midd) MIDD · basing · Too little evidence to rank firmly · 56% evidence 49.1 out of 100 Growth Capital Valuation Relative
15. [Parker-Hannifin Corporation](https://www.sectoralpha.in/us/stocks/ph) PH · quiet · Evidence leans down · 81% evidence 48.6 out of 100 Growth Capital Valuation Relative
16. [JBT Marel Corporation](https://www.sectoralpha.in/us/stocks/jbtm) JBTM · basing · Evidence leans down · 74% evidence 46.9 out of 100 Growth Capital Valuation Relative
17. [Gates Industrial Corporation plc](https://www.sectoralpha.in/us/stocks/gtes) GTES · quiet · Evidence leans down · 81% evidence 44.7 out of 100 Growth Capital Valuation Relative
18. [Graco Inc.](https://www.sectoralpha.in/us/stocks/ggg) GGG · quiet · Evidence leans down · 85% evidence 43.5 out of 100 Growth Capital Valuation Relative
19. [A. O. Smith Corporation](https://www.sectoralpha.in/us/stocks/aos) AOS · turning · Evidence leans down · 81% evidence 43.4 out of 100 Growth Capital Valuation Relative
20. [Ingersoll Rand Inc.](https://www.sectoralpha.in/us/stocks/ir) IR · quiet · Evidence leans down · 74% evidence 43.2 out of 100 Growth Capital Valuation Relative
21. [Pentair plc](https://www.sectoralpha.in/us/stocks/pnr) PNR · turning · Evidence leans down · 81% evidence 42.9 out of 100 Growth Capital Valuation Relative
22. [Regal Rexnord Corporation](https://www.sectoralpha.in/us/stocks/rrx) RRX · turning · Evidence leans down · 81% evidence 42.6 out of 100 Growth Capital Valuation Relative
23. [ITT Inc.](https://www.sectoralpha.in/us/stocks/itt) ITT · quiet · Too little evidence to rank firmly · 58% evidence 42.3 out of 100 Growth Capital Valuation Relative
24. [Symbotic Inc.](https://www.sectoralpha.in/us/stocks/sym) SYM · basing · Evidence leans down · 64% evidence 42.2 out of 100 Growth Capital Valuation Relative
25. [Enpro Inc.](https://www.sectoralpha.in/us/stocks/npo) NPO · quiet · Evidence leans down · 81% evidence 41.3 out of 100 Growth Capital Valuation Relative
26. [Xylem Inc.](https://www.sectoralpha.in/us/stocks/xyl) XYL · basing · Evidence leans down · 81% evidence 39.9 out of 100 Growth Capital Valuation Relative
27. [Cummins Inc.](https://www.sectoralpha.in/us/stocks/cmi) CMI · basing · Evidence leans down · 81% evidence 37.3 out of 100 Growth Capital Valuation Relative
28. [Eaton Corporation plc](https://www.sectoralpha.in/us/stocks/etn) ETN · quiet · Evidence leans down · 81% evidence 37.2 out of 100 Growth Capital Valuation Relative
29. [Generac Holdings Inc.](https://www.sectoralpha.in/us/stocks/gnrc) GNRC · turning · Evidence leans down · 81% evidence 36.8 out of 100 Growth Capital Valuation Relative
30. [Chart Industries, Inc.](https://www.sectoralpha.in/us/stocks/gtls) GTLS · Too little evidence to rank firmly · 36% evidence 31.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Industrial Machinery](https://www.sectoralpha.in/us/sectors/specialty-industrial-machinery), all 30 compared on one page. ## Which companies are close to AMETEK in size? AMETEK is the 7th largest of 57 Specialty Industrial Machinery companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Emerson Electric Co., Illinois Tool Works Inc. and Cummins Inc. Just below it: Rockwell Automation, Inc., Ingersoll Rand Inc. and Otis Worldwide Corporation. ### Specialty Industrial Machinery companies close in size

1. [Emerson Electric Co.](https://www.sectoralpha.in/us/stocks/emr) $92.8 billion
2. [Illinois Tool Works Inc.](https://www.sectoralpha.in/us/stocks/itw) $81.5 billion
3. [Cummins Inc.](https://www.sectoralpha.in/us/stocks/cmi) $68.9 billion
4. AMETEK, Inc. $57 billion
5. [Rockwell Automation, Inc.](https://www.sectoralpha.in/us/stocks/rok) $49.6 billion
6. [Ingersoll Rand Inc.](https://www.sectoralpha.in/us/stocks/ir) $32.5 billion
7. [Otis Worldwide Corporation](https://www.sectoralpha.in/us/stocks/otis) $29.2 billion

[All 57 Specialty Industrial Machinery companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-industrial-machinery#all-companies)

### Companies close in size in other industries

1. [Diamondback Energy, Inc.](https://www.sectoralpha.in/us/stocks/fang) $55.9 billion · Oil & Gas Exploration & Production
2. [Devon Energy Corporation](https://www.sectoralpha.in/us/stocks/dvn) $55.9 billion · Oil & Gas Exploration & Production
3. AMETEK, Inc. $55.3 billion
4. [Strategy Inc](https://www.sectoralpha.in/us/stocks/mstr) $55.2 billion · Software - Application
5. [Natera, Inc.](https://www.sectoralpha.in/us/stocks/ntra) $54.6 billion · Diagnostics & Research

## What else do people ask about AMETEK? ### What is AMETEK's stock price today? AMETEK, Inc.'s stock price is $248.58, +23.0% over the past year. The whole company is worth $57.0 B on the market. In the last 52 weeks it traded between $193 to $255; today it is 90% of the way up from the low, 6.0% above its 200-day average (as of 3 November 2026). ### What were AMETEK's latest quarterly results? AMETEK, Inc. reported revenue of $2.0 B and net profit of $407 M for the Jun 2026 quarter. Revenue rose 15.0% and profit rose 13.5% compared with a year earlier. Earnings per share were $1.77. The operating margin was 26.2%, 0.7 percentage points higher than a year earlier (as of 3 November 2026). ### What is AMETEK's market cap? AMETEK, Inc.'s market capitalisation is $57.0 B at a stock price of $248.58. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is AMETEK performing? AMETEK, Inc.'s share price has been rising for 56 weeks. In its latest quarter, revenue rose 15.0% and profit rose 13.5% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 3 November 2026). ### Will AMETEK's stock price go up? This page does not forecast AMETEK, Inc.'s stock price. What it shows instead: the stock price is $248.58, and it has been rising for 56 weeks. Its P/E of 35.1× is higher than 91% of its own last 5 years (as of 3 November 2026). ### Does AMETEK have too much debt? AMETEK, Inc. has a moderate amount of debt: its debt is 0.57× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is AMETEK in its business cycle? AMETEK, Inc.'s FY25 operating margin was 26.2%, against a 5-year range of 23.6% to 26.2%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 26.2%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the AMETEK story? The main question: results are strong, and the P/E is higher than 91% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is AMETEK a stock worth studying right now? What the numbers show: AMETEK, Inc.'s results are improving, and its P/E is near the top of its own history, higher than 91% of past readings. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- S&P 500 companies: https://www.sectoralpha.in/sp-500-stocks

This is research, not advice. We’re not SEBI-registered.